Explore the Potential with AI-Driven Innovation
This comprehensive focused library is produced on demand with state-of-the-art virtual screening and parameter assessment technology driven by Receptor.AI drug discovery platform. This approach outperforms traditional methods and provides higher-quality compounds with superior activity, selectivity and safety.
We pick out particular compounds from an extensive virtual database of more than 60 billion molecules. The preparation and shipment of these compounds are facilitated by our associate Reaxense.
The library includes a list of the most effective modulators, each annotated with 38 ADME-Tox and 32 physicochemical and drug-likeness parameters. Furthermore, each compound is shown with its optimal docking poses, affinity scores, and activity scores, offering a detailed summary.
We employ our advanced, specialised process to create targeted libraries for enzymes.
Fig. 1. The sreening workflow of Receptor.AI
The procedure entails thorough molecular simulations of the catalytic and allosteric binding pockets, accompanied by ensemble virtual screening that factors in their conformational flexibility. When developing modulators, the structural modifications brought about by reaction intermediates are factored in to optimize activity and selectivity.
Several key aspects differentiate our library:
partner
Reaxense
upacc
Q96MM7
UPID:
H6ST2_HUMAN
Alternative names:
-
Alternative UPACC:
Q96MM7; B9WRT4; B9WRT5; E9PDY5; Q2TB13; Q4VC07; Q6PIC4; Q86SM9; Q8N3T4; Q8NBN4; Q96SJ4
Background:
Heparan-sulfate 6-O-sulfotransferase 2 plays a pivotal role in the sulfation process of heparan sulfate, a critical component of the extracellular matrix. This enzyme's activity is essential for modifying heparan sulfate's structure and function, impacting various biological processes.
Therapeutic significance:
Linked to Paganini-Miozzo syndrome, a neurodevelopmental disorder, understanding the enzyme's role could pave the way for novel therapeutic strategies targeting the underlying genetic variants.